• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORPORATION SUPARTZ FX; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORPORATION SUPARTZ FX; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Model Number 89130-4444-01
Device Problem Insufficient Information (3190)
Patient Problem Anaphylactic Shock (1703)
Event Type  Injury  
Manufacturer Narrative
This case is received by bioventus on (b)(6), 2022 and it was forwarded to manufacturer on december 8.Follow ups for additional information are now in progress in bioventus.
 
Event Description
Unknown - a patient went into anaphylactic shock following a supartz fx injection.
 
Manufacturer Narrative
This case was received by bioventus on december 5, 2022 and it was forwarded to the manufacturer on december 8.This case was filed to the fda on december 27 from the manufacturer and also filed on december 30 from bioventus as 3009595577-2022-00006.No update was provided from the follow up.Dates of the follow up attempts were the followings; dec 7th - email follow up sent to the rep, dec 19th - fax sent to the physician's office, dec 19th - phone call place to sales rep, dec 20th - email sent to follow up with physician, dec 30th - phone call placed to the physician's office.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPARTZ FX
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
SEIKAGAKU CORPORATION
marunouchi center building
6-1, marunouchi 1-chome
chiyoda-ku, tokyo 100-0 005
JA  100-0005
Manufacturer (Section G)
SEIKAGAKU CORPORATION - TAKAHAGI PLANT
258-5, aza-matsukubo
oaza-akahama
takahagi-shi, ibaraki 318-0 001
JA   318-0001
Manufacturer Contact
pharmacovigilance dept
marunouchi center building
6-1, marunouchi 1-chome
chiyoda-ku, tokyo 100-0-005
JA   100-0005
MDR Report Key16051939
MDR Text Key306176476
Report Number9612392-2022-00010
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P980044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/27/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number89130-4444-01
Device Catalogue Number7156-4444
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/24/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Other;
-
-